The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
IL-17A causes depression-like symptoms via NFκB and p38MAPK signaling pathways in mice: Implications for psoriasis associated depression
Abstract
Psoriasis has been shown to be associated with an increased prevalence of comorbid major depression. IL-17A plays an important role in both depression and psoriasis. IL-17A has been shown to be elevated in systemic circulation of psoriatic patients. IL-17A released from different immune cells during psoriasis may be responsible for the development of neuropsychiatric symptoms associated with depression. Therefore, this study explored the association of systemic IL-17A with depression. The present study utilized imiquimod model of psoriatic inflammation as well as IL-17A administration in mice to investigate the effect of IL-17A on depression-like behavior. Psoriatic inflammation led to enhanced IL-17A expression in peripheral immune cells of both innate and adaptive origin. This was associated with increased NFκB/p38MAPK signaling and inflammatory mediators in different brain regions, and depression-like symptoms (as reflected by sucrose preference and tail suspension tests). The role of IL-17A was further confirmed by administering it alone for ten days, followed by assessment of the same parameters. IL-17A administration produced effects similar to psoriasis-like inflammation on neurobehavior and NFκB/p38MAPK pathways. Moreover, both NFκB and p38MAPK inhibitors led to attenuation in IL-17A associated with depression-like behavior via reduction in inflammatory mediators, such as MCP-1, iNOS, IL-6, and CXCL-2. Furthermore, anti-IL17A antibody also led to a reduction in imiquimod-induced depression-like symptoms, as well as NFκB/p38MAPK signaling. The present study shows that IL-17A plays an important role in comorbid depression associated with psoriatic inflammation, where both NFκB and p38MAPK pathways play significant roles via upregulation of inflammatory mediators in the brain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The sustained activation of the IL-17 pathway in chronic social defeat stress conditions suggests a maladaptive neuroimmune response, which may underlie the persistent behavioral changes observed”
From Comparative Analysis of HPA-Axis Dysregulation and Dynamic Molecular Mechanisms in Acute Versus Chronic Social Defeat Stress (2025) · cites this paper as [48]
In the citing paper
“Preclinical studies in rodents corroborate these findings, showing that IL-17A administration induces depressive-like behaviors [48] and stress exposure elevates IL-17A levels [66,67,68,69].”
From Comparative Analysis of HPA-Axis Dysregulation and Dynamic Molecular Mechanisms in Acute Versus Chronic Social Defeat Stress (2025) · cites this paper as [48]
In the citing paper
“administration of IL-17A in rodents promotes depressive-like behaviors (Nadeem et al., 2017)”
From Distinct characteristics of hippocampal pathogenic th17 cells in a mouse model of depression (2018) · cites this paper as Nadeem et al., 2017
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
The tail suspension test: A new method for screening antidepressants in mice
Steru, L., Chermat, R., Thierry, B., & Simon, P. (1985) · Psychopharmacology · doi:10.1007/bf00428203 · Cited by 3,534
Boehncke, W., & Schön, M. P. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61909-7 · Cited by 2,609
Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A. (2007) · Nature Medicine · doi:10.1038/nm1651 · Cited by 1,759
Lowes, M. A., Suárez‐Fariñas, M., & Krueger, J. G. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120225 · Cited by 1,710
Structure and signalling in the IL-17 receptor family
Gaffen, S. L. (2009) · Nature reviews. Immunology · doi:10.1038/nri2586 · Cited by 1,475
Cytokine-Associated Emotional and Cognitive Disturbances in Humans
Reichenberg, A., Yirmiya, R., Schuld, A., Kraus, T., Haack, M., Morag, A., & Pollmächer, T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.445 · Cited by 1,365
Cited by
Sorted by citations
The Bidirectional Relationship of Depression and Inflammation: Double Trouble
Beurel, E., Toups, M., & Nemeroff, C. B. (2020) · Neuron · doi:10.1016/j.neuron.2020.06.002 · Cited by 2,136
Beurel, E., & Lowell, J. A. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.08.001 · Cited by 187
Ni, P., Dong, H., Wang, Y., Zhou, Q., Xu, M., Qian, Y., & Sun, J. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1374-3 · Cited by 160
Kim, J., Suh, Y.-H., & Chang, K.-A. (2021) · Molecular Brain · doi:10.1186/s13041-020-00726-x · Cited by 116
Insights into hidradenitis suppurativa
van Straalen, K. R., Prens, E. P., & Gudjonsson, J. E. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.02.003 · Cited by 109
Th17 cells and inflammation in neurological disorders: Possible mechanisms of action
Shi, Y., Wei, B., Li, L., Wang, B., & Sun, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.932152 · Cited by 108
Roles of Infection in Psoriasis
Zhou, S., & Yao, Z. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136955 · Cited by 95
Bain, K. A., McDonald, E., Moffat, F., Tutino, M., Castelino, M., Barton, A. C., Cavanagh, J., Ijaz, U. Z., Siebert, S., McInnes, I. B., et al. (2019) · British Journal of Dermatology · doi:10.1111/bjd.18008 · Cited by 98
Wang, X., Li, Y., Wu, L., Xiao, S., Ji, Y., Tan, Y., Jiang, C., & Zhang, G. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111065 · Cited by 95
Nadeem, A., Ahmad, S. F., Al-Harbi, N. O., Attia, S. M., Bakheet, S. A., Ibrahim, K. E., Alqahtani, F., & Alqinyah, M. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.02.031 · Cited by 92
Self-citationDionysopoulou, S., Charmandari, E., Bargiota, Α., Vlahos, N., Mastorakos, G. P., & Valsamakis, G. (2021) · Nutrients · doi:10.3390/nu13020498 · Cited by 91
Hong, X., Zhou, Y. M., Zhu, Z., Li, Y., Zuo, L., Zhang, Y., Hu, X., Zhu, F., Wang, Y., Fang, M., et al. (2023) · Environment International · doi:10.1016/j.envint.2023.107759 · Cited by 85
Review of microbiota gut brain axis and innate immunity in inflammatory and infective diseases
Yuan, C., He, Y., Xie, K., Feng, L., Gao, S., & Cai, L. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1282431 · Cited by 87
Fabrazzo, M., Cipolla, S., Signoriello, S., Camerlengo, A., Calabrese, G., Giordano, G. M., Argenziano, G., & Galderisi, S. (2021) · European Psychiatry · doi:10.1192/j.eurpsy.2021.2249 · Cited by 81
Inflammation in the pathogenesis of depression: a disorder of neuroimmune origin
Corrigan, M., O’Rourke, A. M., Moran, B., Fletcher, J. M., & Harkin, A. (2023) · Neuronal Signaling · doi:10.1042/ns20220054 · Cited by 81
Fagni, F., Bettiol, A., Talarico, R., Lopalco, G., Silvestri, E., Urban, M. L., Russo, P., Scala, G. D., Emmi, G., & Prisco, D. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217108 · Cited by 73
Advances in the study of IL-17 in neurological diseases and mental disorders
Lu, Y., Zhang, P., Xu, F., Zheng, Y., & Zhao, H. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1284304 · Cited by 71
Lee, B., Kwon, J.-T., Jeong, Y., Caris, H., Oh, D., Feng, M., Mejia, I. D., Zhang, X., Ishikawa, T., Watson, B. R., et al. (2025) · Cell · doi:10.1016/j.cell.2025.03.005 · Cited by 74
Assessing and Improving Psychological Well-Being in Psoriasis: Considerations for the Clinician
Blackstone, B., Patel, R., & Bewley, A. (2022) · Psoriasis Targets and Therapy · doi:10.2147/ptt.s328447 · Cited by 69
Distinct characteristics of hippocampal pathogenic th17 cells in a mouse model of depression
Beurel, E., Lowell, J. A., & Jope, R. S. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.04.012 · Cited by 65
Nadeem, A., Ahmad, S. F., Al-Harbi, N. O., Attia, S. M., Alshammari, M. A., Alzahrani, K. S., & Bakheet, S. A. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.09.012 · Cited by 65
Self-citationWoo, Y. R., Park, C. J., Kang, H., & Kim, J. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197041 · Cited by 64
Targeting the Adaptive Immune System in Depression: Focus on T Helper 17 Cells
Beurel, E., Medina-Rodriguez, E. M., & Jope, R. S. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000256 · Cited by 60
The role of Th17 cells in the pathophysiology of pregnancy and perinatal mood and anxiety disorders
Osborne, L. M., Brar, A., & Klein, S. L. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.11.015 · Cited by 62
Nadeem, A., Ahmad, S. F., Attia, S. M., AL-Ayadhi, L. Y., Bakheet, S. A., & Al-Harbi, N. O. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.12.002 · Cited by 63
Langley, R. G. B., Kimball, A. B., Nak, H., Xu, W., Pangallo, B. A., Osuntokun, O. O., Agada, N. O., & Reich, K. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.15242 · Cited by 61
Han, M., Ban, J.-J., Bae, J.-S., Shin, C.-Y., Lee, D. H., & Chung, J. H. (2017) · Scientific Reports · doi:10.1038/s41598-017-15773-z · Cited by 54
Zafiriou, E., Daponte, A., Siokas, V., Tsigalou, C., Dardiotis, E., & Bogdanos, D. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.699848 · Cited by 77
Immunotherapy for depression: Recent insights and future targets
Bai, Y., Cai, Y., Chang, D., Li, D., Huo, X., & Zhu, T. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108624 · Cited by 56
The Prevalent Comorbidome at the Onset of Psoriasis Diagnosis
Buja, A., Miatton, A., Cozzolino, C., Brazzale, A. R., Bue, R. L., Mercuri, S. R., Proft, F. N., Kridin, K., Cohen, A. D., & Damiani, G. B. (2023) · Dermatology and Therapy · doi:10.1007/s13555-023-00986-0 · Cited by 50
Nadeem, A., Ahmad, S. F., Attia, S. M., AL-Ayadhi, L. Y., Al-Harbi, N. O., & Bakheet, S. A. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.08.020 · Cited by 50
Self-citationMechanisms and Therapeutic Targets of Depression After Intracerebral Hemorrhage
Wu, Y., Wang, L., Hu, K., Yu, C., Zhu, Y., Zhang, S., & Shao, A. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00682 · Cited by 49
Psoriasis and suicidality: A review of the literature
Liang, S. E., Cohen, J. M., & Ho, R. S. (2018) · Dermatologic Therapy · doi:10.1111/dth.12771 · Cited by 49
Ishikawa, Y., Kitaoka, S., Kawano, Y., Ishii, S., Suzuki, T., Wakahashi, K., KATO, T., Katayama, Y., & Furuyashiki, T. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15203 · Cited by 50
Circulating T helper 17 and IFN-γ positive Th17 cells in Major Depressive Disorder
Ghosh, R., Kumar, P. K., Mitra, P., Purohit, P., Nebhinani, N., & Sharma, P. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112811 · Cited by 47
The Cytokine IL-17A as a Marker of Treatment Resistance in Major Depressive Disorder?
Nothdurfter, C., Milenkovic, V. M., Sarubin, N., Hilbert, S., Manook, A., Weigl, J., Almeqbaali, K., Wetzel, C. H., Rupprecht, R., & Baghai, T. C. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14636 · Cited by 38
The Mind Body Connection in Dermatologic Conditions: A Literature Review
Mar, K., & Rivers, J. K. (2023) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/12034754231204295 · Cited by 54
Yang, Y., Huang, T., Zhang, H., Li, X., Shi, S., Tian, X., Huang, Z., Zhang, R., Liu, Z., & Cheng, Y. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154602 · Cited by 46
Modulation of neuroimmune cytokine networks by antidepressants: implications in mood regulation
Nava, R. G., Adri, A. S., Filgueiras, I. S., Nóbile, A. L., Barcelos, P. M., Corrêa, Y. L. G., de Oliveira, S. F., Cabral‐Miranda, G., Dias, H. D., Schimke, L. F., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03532-y · Cited by 53
Yan, C., Wu, L., Zeng, N.-X., Li, H., Wang, H., Liu, K., Gong, X., & Luo, W.-L. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.320993 · Cited by 44
Dill‐McFarland, K. A., Altman, M. C., Esnault, S. J., Jarjour, N. N., Busse, W. W., & Rosenkranz, M. A. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.07.025 · Cited by 44
He, Y., Li, W., Wang, Y., Tian, Y., Chen, X., Wu, Z., Lan, T., Li, Y., Bai, M., Liu, J., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.03.131 · Cited by 46
The Role of Inflammation in the Pathophysiology of Depression and Suicidal Behavior
Serafini, G., Costanza, A., Aguglia, A., Amerio, A., Trabucco, A., Escelsior, A., Sher, L., & Amore, M. (2022) · Medical Clinics of North America · doi:10.1016/j.mcna.2022.09.001 · Cited by 48
Th17 Cells in Depression: Are They Crucial for the Antidepressant Effect of Ketamine?
Cui, M., Dai, W., Kong, J., & HongZhi, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.649144 · Cited by 38
Caccavale, S., Tancredi, V., Boccellino, M. P., Babino, G., Fulgione, E., & Argenziano, G. (2023) · Life · doi:10.3390/life13010189 · Cited by 39
Chaudhary, R., Prasad, A., Agarwal, V., Rehman, M., Kumar, A., Kaushik, A. S., Srivastava, S., Srivastava, S., & Mishra, V. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111046 · Cited by 40
Th17 Cells, Glucocorticoid Resistance, and Depression
Khantakova, J. N., Mutovina, A., Ayriyants, K. A., & Bondar, N. P. (2023) · Cells · doi:10.3390/cells12232749 · Cited by 36
New Frontiers in Psoriatic Disease Research, Part II: Comorbidities and Targeted Therapies
Yan, D., Blauvelt, A., Dey, A. K., Golpanian, R. S., Hwang, S. T., Mehta, N. N., Myers, B. A., Shi, Z., Yosipovitch, G., Bell, S. J., et al. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.02.743 · Cited by 35
T helper cells in depression: central role of Th17 cells
Ghosh, R., Mitra, P., Kumar, P. V. S. N. K., Goyal, T., & Sharma, P. (2021) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2021.1965535 · Cited by 37
Proinflammatory cytokines and neuropeptides in psoriasis, depression, and anxiety
Keenan, E. L., & Granstein, R. D. (2025) · Acta Physiologica · doi:10.1111/apha.70019 · Cited by 39
Kulkarni, N. P., Vaidya, B., Narula, A. S., & Sharma, S. S. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210608165509 · Cited by 31
Nadeem, A., Al-Harbi, N. O., Alfardan, A. S., Ahmad, S. F., Alasmari, A. F., & Al‐Harbi, M. M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.123 · Cited by 31
Self-citationMatelski, L., Morgan, R. K., Grodzki, A. C., de Water, J. V., & Lein, P. J. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0647-2 · Cited by 31
Pang, X., Zhang, K., Huang, J. M., Wang, H., Gao, L., Wang, T., Sun, Y., Chen, L., & Wang, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071822 · Cited by 30
Nadeem, A., Al-Harbi, N. O., Ahmad, S. F., Ibrahim, K. E., Alotaibi, M. R., Siddiqui, N. M., AlSharari, S. D., Attia, S. M., & Al-Harbi, M. M. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.03.001 · Cited by 29
Self-citationVenkatachalam, K., Eissa, N., Awad, M. A., Jayaprakash, P., Zhong, S., Stölting, F., Stark, H., & Sadek, B. S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111517 · Cited by 30
Liu, W., Song, W., Luo, Y., Dan, H., Li, L., Zhang, Z., Zhou, D., & You, P. (2022) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2022.07.003 · Cited by 25
Nadeem, A., Ahmad, S. F., Al-Harbi, N. O., Sarawi, W. S., Attia, S. M., Alanazi, W. A., Ibrahim, K. E., Alsanea, S., Alqarni, S. A., Alfardan, A. S., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108703 · Cited by 26
Self-citationChowdhury, N. I., Chandra, R. K., Li, P., Ely, K., & Turner, J. H. (2019) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22287 · Cited by 24
Graves’ disease as a driver of depression: a mechanistic insight
Song, Y., Wang, X., Ma, W., Yang, Y., Yan, S., Sun, J., Zhu, X., & Tang, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1162445 · Cited by 26
Alotaibi, M. R., Alaqil, F. A., Alqahtani, F., Alanazi, M., Nadeem, A., Ahmad, S. F., Lapresa, R., Alharbi, M., Alshammari, A., Alotaibi, M., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.891593 · Cited by 23
Self-citationAssociation of Psoriasis With Anxiety and Depression: A Case–Control Study in Chinese Patients
Jing, D., Xiao, H., Shen, M., Chen, X., Han, X., Kuang, Y., Zhu, W., & Xiao, Y. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.771645 · Cited by 20
Th17-cells in depression: Implication in multiple sclerosis
Melnikov, M., & Lopatina, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1010304 · Cited by 20
Optimization of psoriasis mouse models
Karamani, C., Antoniadou, I. T., Dimou, A., Andreou, E., Kostakis, G. E., Sideri, A., Vitsos, A., Gkavanozi, A., Sfiniadakis, I., Skaltsa, H. D., et al. (2021) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2021.107054 · Cited by 19
Psychological burden of psoriatic patients in a German university hospital dermatology department
Sondermann, W., Fiege, O., Körber, A., & Scherbaum, N. (2020) · The Journal of Dermatology · doi:10.1111/1346-8138.15721 · Cited by 19
Algahtani, M., Alshehri, S., Alqarni, S. S., Ahmad, S. F., Al-Harbi, N. O., Alqarni, S. A., Alfardan, A. S., Ibrahim, K. E., Attia, S. M., & Nadeem, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098101 · Cited by 19
Self-citationLi, X., Liu, T., Mo, X., Wang, R., Kong, X., Shao, R., McIntyre, R. S., So, K., & Lin, K. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.389360 · Cited by 18
An update on the impact of depression on the treatment of psoriasis
Bell, K. A., Balogh, E. A., & Feldman, S. R. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1849141 · Cited by 18
Apigenin ameliorates imiquimod-induced psoriasis in C57BL/6J mice by inactivating STAT3 and NF-κB
Meng, X., Zheng, S., Yin, Z., Wang, X., Yang, D., Zou, T., Li, H., Chen, Y., Liao, C., Xie, Z., et al. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250018 · Cited by 17
Yang, X., Yang, C., Wang, L., Cao, Z., Wang, Y., Cheng, C., Zhao, G., & Zhao, Y. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5009 · Cited by 17
Katamanin, O. M., Tan, I. J., Barry, J., & Jafferany, M. (2024) · American Journal of Clinical Dermatology · doi:10.1007/s40257-024-00905-9 · Cited by 16
Programming of Vascular Dysfunction by Maternal Stress: Immune System Implications
Costa, T. J. D., de Oliveira, J. C., Giachini, F. R. C., Lima, V. V., Tostes, R. C., & Bomfim, G. F. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.787617 · Cited by 16
Childhood trauma: a risk for major depression in patients with psoriasis
Erfanian, M. (2018) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2018.1452521 · Cited by 15
Fu, Y., Xie, T., Zhang, Y., & Gu, Z.-H. (2022) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2022.102181 · Cited by 14
Koy, E. H. S., Labauge, P. M., Baillet, A. C., Prati, C., Marotte, H., & Pers, Y. (2021) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x211025894 · Cited by 15
Brain inflammaging in the pathogenesis of late-life depression
Ishizuka, T., Nagata, W., Nakagawa, K., & Takahashi, S. (2024) · Human Cell · doi:10.1007/s13577-024-01132-4 · Cited by 13
Sondermann, W., Schreiber, A., Körber, A., Fiege, O., Scherbaum, N., Benson, S., & Schedlowski, M. (2020) · European Journal of Dermatology · doi:10.1684/ejd.2020.3755 · Cited by 13
Almulla, A., Jaleel, A. K. A., Algon, A. A. A., Tunvirachaisakul, C., Hassoun, H., Al-hakeim, H., & Maes, M. (2022) · medRxiv · doi:10.3390/brainsci13071073 · Cited by 10
Serum cytokines associated with behavior: A cross-sectional study in 5-year-old children
Barbosa, S., Khalfallah, O., Forhan, A., Galéra, C., Heude, B., Glaichenhaus, N., & Davidovic, L. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.01.005 · Cited by 15
Wintermann, G., Bierling, A. L., Peters, E. M. J., Abraham, S., Beissert, S., & Weidner, K. (2023) · Stress and Health · doi:10.1002/smi.3263 · Cited by 15
Interleukin-17A and Chronic Stress in Pregnant Women at 24–28 Weeks Gestation
Moore, T. A., Case, A. J., Mathews, T. L., Epstein, C. M., Kaiser, K. L., & Zimmerman, M. C. (2018) · Nursing Research · doi:10.1097/nnr.0000000000000334 · Cited by 12
The complex relationship between gut microbiota dysregulation and mood disorders: A narrative review
Minuti, A., Brufani, F., Menculini, G., Moretti, P., & Tortorella, A. A. V. (2022) · Current Research in Neurobiology · doi:10.1016/j.crneur.2022.100044 · Cited by 13
Yang, J., Jia, Y., Guo, T., Zhang, S., Huang, J., Lu, H., Li, L., Xu, J., Liu, G., & Xiao, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136063 · Cited by 11
CCR6–CCL20-Mediated Immunologic Pathways in Inflammatory Bowel Disease
Ranasinghe, R., & Eri, R. D. (2018) · Gastrointestinal Disorders · doi:10.3390/gidisord1010003 · Cited by 11
Downregulated NPAS4 in multiple brain regions is associated with major depressive disorder
Selçuk, B., Aksu, T., Dereli, O., & Adebalı, O. (2023) · Scientific Reports · doi:10.1038/s41598-023-48646-9 · Cited by 11
Yoshikawa, S., Taniguchi, K., Sawamura, H., Ikeda, Y., Asai, T. T., Tsuji, A., & Matsuda, S. (2023) · Livers · doi:10.3390/livers3010002 · Cited by 9
Chen, T., Zhu, S., Xu, S., Wang, Y., Aji, A., Zhang, C., Wang, H., Li, F., & Chu, Y. (2023) · Experimental Dermatology · doi:10.1111/exd.14914 · Cited by 10
Dorai, S., & Anand, D. A. (2022) · Cells · doi:10.3390/cells11233867 · Cited by 10
Wang, J., Zhou, L., Hou, H., Li, J., Zhao, X., Li, J., Li, J., Niu, X., Hou, R., & Zhang, K. (2023) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.15975 · Cited by 9
Demir, E. A., Duran, G. G., Küçük, M. U., Doğan, H. D., Tutuk, O., Açıkgül, F. Ç., Bayırlı, M., Tümer, C., & Duran, N. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02831-5 · Cited by 8
Kunisawa, K., Shan, J., Lu, Q., Yang, Y., Kosuge, A., Kurahashi, H., Saito, K., Zou, L., Nabeshima, T., & Mouri, A. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03692-z · Cited by 9
The role of interleukin-17 in neurological disorders
Park, S. E., Ferreira, A. F. F., Kwon, H., Yu, J., Diniz, L., Ulrich, H., Britto, L. R. G., & Kim, E. (2025) · Animal Cells and Systems · doi:10.1080/19768354.2025.2510994 · Cited by 8
Wang, Y., Xing, J., Liang, Y., Liang, H., Niu, X., Li, J., & Zhang, K. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1659346 · Cited by 8
Maldonado-García, J. L., Pérez‐Sánchez, G., Becerril‐Villanueva, E., Álvarez-Herrera, S., Pavón, L., Sánchez‐Torres, L. E., Gutiérrez‐Ospina, G., Girón‐Pérez, M. I., Damián-Morales, G., Maldonado-Tapia, J. O., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16111525 · Cited by 8
Pan, T., Gallo, M. E., Donald, K. A., Webb, K., & Bath, K. G. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100760 · Cited by 9
Silva, Z. M., de Toledo, D. N. M., Pio, S., Machado, B. A. A., dos Santos, P. V., Hó, F. G., Medina, Y. N., Cordeiro, P. H. D. M., Perucci, L. O., Pinto, K. M. D. C., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1394456 · Cited by 8
Li, S., Lv, D., Qian, C., Jiang, J., Zhang, P., Xi, C., Wu, L., Gao, X., Fu, Y., Zhang, D., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14361 · Cited by 10
Moriyama, N., Saito, M., Ono, Y., Yamashita, K., Aoi, T., & Kotani, J. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134309 · Cited by 7
Stress-induced VIPergic activation mediates microbiota/Th17cell-dependent depressive-like behaviors
Medina-Rodriguez, E. M., Han, D., Zeltzer, S. E., Moraskie, M., O’Connor, G., Daunert, S., & Beurel, E. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.10.016 · Cited by 7
Tifner, V., Daray, F. M., López-Carvajal, J. E., Arena, Á. R., Grendas, L. N., Casiani, R. I. Á., Olaviaga, A., Chiapella, L. C., Penna, M. B., Hunter, F., et al. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103563 · Cited by 7
Metadata
- Authors
- Nadeem, A., Ahmad, S. F., Al-Harbi, N. O., Fardan, A. S., El-Sherbeeny, A. M., Ibrahim, K. E., & Attia, S. M.
- Affiliations
- King Saud University (SA)
- Corresponding author
- Nadeem, Ahmed
- Venue
- Cytokine
- Publisher
- Elsevier BV
- Published
- 2017-09
- Volume
- 97
- Pages
- 14-24
- ISSN
- 1043-4666 (ISSN-L)
- OpenAlex
- W2617690685
- Cited by
- 147
- References
- 54
- Citations by year
- 2026: 10 · 2025: 18 · 2024: 10 · 2023: 31 · 2022: 24 · 2021: 18 · 2020: 14 · 2019: 6 · 2018: 14 · 2017: 2
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cytokine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deanship of Scientific Research at King Saud University (RG-1438-019)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- IL-17A, depression-like behavior, psoriasis, NF-κB signaling, p38 MAPK signaling, neuroinflammation, anti-IL-17A antibody, comorbid depression
- MeSH terms
- Imiquimod, Aminoquinolines, Animals, Brain, Depression, Major Depressive Disorder, Depressive Disorder, Major, Disease Models, Animal, Humans, Inflammation, Psoriasis, NF-kappa B, Interleukin-17, MAP Kinase Signaling System, p38 Mitogen-Activated Protein Kinases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review